Trial Profile
A multi-center, double-blind, randomized, placebo-controlled study of orally administered SP01A as monotherapy treatment of HIV-infected patients
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Procaine (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- 17 Oct 2005 New trial record.